PROTEUS Reconsidered: Rethinking Success When Most Patients Never Become Disease-Free
A provocative reassessment of the PROTEUS study is challenging what it means to call a cancer trial “positive” when most...
Rowan B. covers cancer and oncology, including tumor biology, screening, diagnostics, treatment research, clinical trials, and survivorship science.
A provocative reassessment of the PROTEUS study is challenging what it means to call a cancer trial “positive” when most...
Bacteria may soon do more than cause infection: they could help doctors detect, target and treat cancer. A new review...
Urological cancers may be hiding an underused layer of immune surveillance, according to a new review that places unconventional T...
Antisense oligonucleotides, or ASOs, are emerging as precision tools for suppressing disease-causing proteins, but their effectiveness depends on a difficult...
NRG Oncology has announced a broad reshaping of its scientific and operational leadership, appointing five experienced cancer researchers and clinical...
A new study is drawing attention to a possible biological pathway connecting polluted air with lung cancer: the chemical changes...
Lung adenocarcinoma, the most common histological form of lung cancer, can appear to have been completely removed after surgery while...
Lung cancer may soon be easier to detect with a technology that sounds more like a laboratory scanner than a...
Prostate cancer does not advance as a single, uniform disease. Within the same tumor, some glands may retain relatively organized...
Johns Hopkins Experts Co-Author New Treatment Framework for Hepatocellular Carcinoma A consortium of North American liver cancer specialists has introduced...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine